Treosulfan (Trecondi Ideogen)

treosulfan · Insel Gruppe AG / University Hospital Bern

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Treosulfan (Trecondi Ideogen), covering 2024-07-08 to 2024-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients [Phase 2]

See pricing